Yuzuru Ikehara Selected Research

Disease Progression

10/2012	LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
1/2011	Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuzuru Ikehara Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 01/2006
14	Infections 12/2016 - 04/2002
12	Stomach Neoplasms (Stomach Cancer) 06/2015 - 04/2002
8	Liver Cirrhosis (Hepatic Cirrhosis) 03/2016 - 01/2011
6	Fibrosis (Cirrhosis) 01/2022 - 01/2011
6	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2005
5	Carcinogenesis 03/2016 - 03/2003
4	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 05/2014
3	Adenocarcinoma 11/2014 - 03/2012
3	Colonic Neoplasms (Colon Cancer) 03/2014 - 09/2003
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2013 - 01/2011
2	COVID-19 04/2024 - 01/2022
2	Vasculitis (Vasculitides) 01/2022 - 01/2022
2	Asthma (Bronchial Asthma) 01/2022 - 09/2016
2	Carcinoma (Carcinomatosis) 01/2020 - 03/2014
2	Thrombosis (Thrombus) 01/2017 - 01/2016
2	Hepatitis 10/2013 - 01/2013
2	Cholangiocarcinoma 06/2013 - 07/2010
2	Disease Progression 10/2012 - 01/2011
2	Neoplasm Micrometastasis 07/2010 - 01/2006
1	Thromboinflammation 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Ulcer 12/2021
1	Skin Ulcer 12/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2017
1	Neuroendocrine Carcinoma 12/2017

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
9	LectinsIBA 11/2014 - 01/2010
7	AntigensIBA 05/2012 - 02/2008
6	Polysaccharides (Glycans)IBA 03/2014 - 03/2009
6	Liposomes (Liposome)IBA 07/2010 - 02/2007
5	Glycoproteins (Glycoprotein)IBA 03/2014 - 01/2010
4	wisteria lectinIBA 03/2016 - 07/2010
3	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2022 - 09/2016
3	LigandsIBA 11/2021 - 06/2013
3	Viral AntigensIBA 12/2016 - 08/2010
3	OvalbuminIBA 09/2016 - 02/2008
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2013 - 08/2005
3	Carrier Proteins (Binding Protein)IBA 01/2013 - 01/2010
3	Monoclonal AntibodiesIBA 08/2010 - 01/2005
2	AutoantibodiesIBA 04/2024 - 02/2009
2	EpitopesIBA 04/2024 - 01/2010
2	Epidermal Growth Factor (EGF)IBA 01/2023 - 01/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 12/2021 - 11/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021 - 04/2016
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2021 - 01/2020
2	CollagenIBA 01/2019 - 12/2016
2	Peptides (Polypeptides)IBA 12/2017 - 03/2014
2	Macrophage Colony-Stimulating FactorIBA 03/2016 - 03/2014
2	CarbohydratesIBA 05/2014 - 02/2008
2	GlycopeptidesIBA 03/2014 - 06/2013
2	Sialic AcidsIBA 11/2013 - 08/2005
2	villinIBA 01/2013 - 01/2005
2	Green Fluorescent ProteinsIBA 03/2012 - 01/2006
2	CytokinesIBA 02/2009 - 01/2006
2	CarcinogensIBA 03/2003 - 04/2002
1	Small Cytoplasmic RNAIBA 04/2024
1	Interferon Type IIBA 04/2024
1	AntibodiesIBA 04/2024
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2023
1	AndrogensIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	Coloring Agents (Dyes)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	AmphiregulinIBA 01/2022
1	ParaffinIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 12/2021
1	calcium phosphateIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2021
1	Essential Amino AcidsIBA 09/2021
1	Fusion Regulatory Protein-1IBA 01/2021
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 01/2020
1	Large Neutral Amino Acid-Transporter 1IBA 11/2019
1	Neutral Amino AcidsIBA 11/2019
1	Plasma GasesIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Aldehyde DehydrogenaseIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	ChromograninsIBA 12/2017

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2005
3	Drug Therapy (Chemotherapy) 12/2020 - 01/2006
2	Transplantation 01/2022 - 12/2020
2	Immunotherapy 11/2021 - 02/2008
2	Intraperitoneal Injections 12/2020 - 07/2010
1	Castration 01/2023
1	Lung Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2022